Document Detail


Inflammation, reactive oxygen species and cytochrome P450.
MedLine Citation:
PMID:  15035735     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Inflammation may ultimately result from damage to membrane lipids by reactive oxygen species (ROS) such as peroxide, superoxide anion, hydroxyl radical and singlet oxygen. This study compares some of the methods used to determine ROS-ethane exhalation, malondialdehyde quantified as thiobarbituric acid-reacting materials, and luminol-activated chemiluminescence (LAC)-and explores possible relationships with oedema formation in the rat foot-pad model. Iron nitrilotriacetate was the most effective of the model compounds tested in producing lipid peroxidation and ethane exhalation in mice. In the mouse and the rat, iron nitrilotriacetate caused increased ethane exhalation and concomitant increases in liver and kidney malondialdehyde. In the rat foot-pad oedema model, the challenge with Freund's complete adjuvant produced maximum malondialdehyde and maximum LAC in the inflamed paw 8 h after dosing, at which time oedema had also reached a high level. These effects were attributed mainly to hydroxyl radical and singlet oxygen. The inhibition of oedema by four anti-inflammatory drugs correlated well with LAC but less well with inhibition of malondialdehyde production. This study shows good agreement between different methods of determining ROS formation, and that inhibition of ROS formation in vivo is paralleled by a decrease in inflammation.
Authors:
Andrew M Symons; Laurence J King
Related Documents :
10416025 - Dynamics of antioxidant action of ubiquinol: a reappraisal.
8661195 - Effects of lipopolysaccharide on intestinal injury; potential role of nitric oxide and ...
16162015 - Synthesis and evaluation of neuroprotective alpha,beta-unsaturated aldehyde scavenger h...
19364325 - Dihydroquercetin (taxifolin) and other flavonoids as inhibitors of free radical formati...
9581925 - Beef color update: the role for vitamin e.
18353295 - Production of lactose-free galacto-oligosaccharide mixtures: comparison of two cellobio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Inflammopharmacology     Volume:  11     ISSN:  0925-4692     ISO Abbreviation:  Inflammopharmacology     Publication Date:  2003  
Date Detail:
Created Date:  2004-03-23     Completed Date:  2004-10-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9112626     Medline TA:  Inflammopharmacology     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  75-86     Citation Subset:  -    
Affiliation:
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs descr...
Next Document:  Treating inflammation: some (needless) difficulties for gaining acceptance of effective natural prod...